Isolation, identification and prokaryotic expression of a bacteriocin-like substance from Bacillus licheniformis.

Xiuju YU; Xiaotao Han; Yuyu LI; Zheng Sun; Changsheng Dong

Return

Isolation, identification and prokaryotic expression of a bacteriocin-like substance from Bacillus licheniformis.

Author: Xiuju YU ¹ ; Xiaotao HAN ¹ ; Yuyu LI ¹ ; Zheng SUN ¹ ; Changsheng DONG ¹
Author Information

1. College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, Shanxi, China.
Publication Type:Journal Article
Keywords: Bacillus licheniformis; antibacterial activity; bacteriocin-like; pH stability; thermal stability
MeSH: Animals; Anti-Bacterial Agents/pharmacology*; Bacillus licheniformis; Bacteriocins/pharmacology*; China; Chromatography, Liquid; Escherichia coli/genetics*; Listeria monocytogenes; RNA, Ribosomal, 16S; Staphylococcus aureus; Tandem Mass Spectrometry
From: Chinese Journal of Biotechnology 2021;37(7):2453-2462
CountryChina
Language:Chinese
Abstract: The ban on addition of antibiotics in animal feed in China has made the search for new antibiotics substitutes, e.g. bacteriocin, a hot topic in research. The present study successfully isolated an antibacterial substance producing strain of Bacillus sp. from alpaca feces by agar diffusion method, using Escherichia coli, Salmonella enterica, Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus luteus and Listeria monocytogenes as indicator bacteria. The isolated strain was named as B. licheniformis SXAU06 based on colony morphology, Gram staining and 16S rRNA gene sequence. The antibacterial substance was isolated and purified through a series of procedures including (NH4)2SO4 precipitation, chloroform extraction, molecular interception and SDS-PAGE analysis. Bioinformatics analysis of the LC-MS/MS data indicated that the antibacterial substance was a bacteriocin-like substance (BLIS) with an approximate molecular weight of 14 kDa, and it was designated as BLIS_SXAU06. BLIS_SXAU06 exhibited high resistance to treatment of proteinase K, high temperature, high acidity and alkalinity. BLIS_SXAU06 was heterologously expressed in E. coli and the recombinant BLIS_SXAU06 exhibited effective antibacterial activity against S. aureus, S. epidermidis, M. luteus, and L. monocytogenes, showing potential to be investigated further.